When?
Start:
May 19, 2022
12:00 PM
End:
May 19, 2022
1:00 PM
Speakers
Débora Sobral,
Founder and CEO, ClinBiz
Lief Kuse
Trailblazer of Drug Development Outsourcing, Pharall GmbH
Innovative financing strategies for biotechs; Reducing capital investment up to 20% with clinical trial scenario modelling. Leif Kuse, CEO of Pharall GmbH, the first group purchasing organization for clinical trial services.
Published on June 3, 2021
Strengthen your processes and increase data-driven decision-making for faster study start-ups.
When?
Start:
May 19, 2022
12:00 PM
End:
May 19, 2022
1:00 PM
Speakers
Débora Sobral,
Founder and CEO, ClinBiz
Lief Kuse
Trailblazer of Drug Development Outsourcing, Pharall GmbH
Strengthen your processes and increase data-driven decision-making for faster study start-ups.
RESOURCES
Explore Expert Insights and Resources for Clinical Excellence
Webinars
Raising capital in biotech has never been simple. In today’s environment, it requires more than a strong scientific story. It requires credibility, precision, and investor confidence.
Blogs
Clinical Maestro® launches Clinical Maestro® 5.0 with Clinical Maestro AI — transforming clinical outsourcing. Learn how sponsors and CROs benefit from vendor intelligence, rate card compliance, change order simplification, and cost transparency.
Case Studies
Faced with inefficiencies, compliance risks, and fragmented communication, a biopharma company dramatically enhanced its vendor governance by implementing VISION!
DEMO
Request a demo
Discover how Clinical Maestro®’s advanced solutions can streamline your clinical trial operations. Request a personalized demo to explore how our tools transform budgeting, vendor management, and outsourcing efficiency for pharma and biotech.

